Massive 3rd
Party Recognition
If
this is your first time hearing about Immunocal, we believe you are
about to be blown away by the documentation, credibility, validated
scientific data and clinical trials that surround this amazing natural
substance.
If
you have heard about Immunocal before, yet didn't realize. We believe
you are about to be awakened!
Immunocal is
not just another immune enhancing product on the market.
Immunocal is
not just another 100% natural supplement you can buy.
Immunocal is
not just another whey protein powder you can buy anywhere.
Immunocal is
not just part of an opportunity, it is the foundation of a marketing
dynasty.
IMMUNOCAL IS:
Currently
Proven with 70
International Medical Patents, including;
ANTI-CANCER, HIV-Treatment and
Improved Immune Response.
This
list of patents continues to grow...
Backed
by over 30
years of real science, originally funded by the Canadian Government
at
McGill
University in Montreal Canada.
Currently
proven by 34 (and
counting) completed, double blind, placebo
controlled studies
which are published in PEER REVIEWED Medical Journals.
Marketed
by a 13 year
old, PUBLICLY
TRADED RESEARCH COMPANY
which
chose MLM as their vehicle of choice to get Immunocal in the
hands of the People.
Two
years ago, this company shifted gears and began a massive campaign to
spread internationally. They shifted from being focused on RESEARCH to
blending research and MARKETING, thereby turning a less than average
marketing plan, into an INDUSTRY LEADING POWER PLAN that has turned
Immunotec Research into the company that will soon be known as the GREATEST OPPORTUNITY
OF THE CENTURY.
|


|
Immunotec
Inc. congratulates Dr. Luc Montagnier for winning the 2008
Nobel Prize in Medicine for his 1984 discovery, with Françoise
Barré–Sinoussi, of the Human Immunodeficiency Virus (HIV).
Drs.
Montagnier and
Barré-Sinoussi first understood that HIV “impaired the immune system
because of massive virus replication and cell damage to lymphocytes.”
Their seminal work set the stage for understanding the biology of the
disease and current modalities of treatment. In addition, it led to
development of methods of diagnosis and blood screening that has
mitigated the spread of the disease.
Dr. Montagnier and his colleagues edited Oxidative Stress in Cancer,
AIDS, and Neurodegenerative Diseases, devoting an entire
chapter to a paper co-authored by Immunotec founding scientist Dr.
Gustavo Bounous, entitled;
Nutriceutical Modulation of Glutathione with a Humanized Native Milk
Serum Protein Isolate, Immunocal: Application in AIDS and
Cancer,
|
|